City

Guangdong (3)

Shibin Al Kawm (1)

Condition

Hepatic Ascites (4)

Overall Status

Recruiting (2)

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Protgen Ltd (3)

Hala Abd EL-Tawab Ibrahim Radwan (1)

Collaborator

Intervention

recombinant human serum albumin (3)

human serum albumin (2)

etilefrine (1)

hypertonic saline solution (1)

oral standard diuretics therapy (1)

sodium chloride injection (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

hepatic ascites

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

Not yet recruiting

Hepatic Ascites

Recombinant Human Serum Albumin
Human serum albumin

Guangdong, Shenzhen, China

Shenzhen Protgen Ltd

May 5, 2023

Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

Recruiting

Hepatic Ascites

Recombinant Human Serum Albumin
Human serum albumin

Guangdong, Shenzheng, China

Shenzheng Protgen Ltd

Feb 9, 2022

Hepatic Ascites Trial in Guangdong (recombinant human serum albumin, Sodium Chloride Injection)

Recruiting

Hepatic Ascites

recombinant human serum albumin
Sodium Chloride Injection

Guangdong, Shenzheng, China

Shenzheng Protgen Ltd

Dec 20, 2021

Hepatic Ascites Trial in Shibin Al Kawm (Oral standard diuretics therapy, Hypertonic saline solution, Etilefrine)

Completed

Hepatic Ascites

Oral standard diuretics therapy
+2 more

Shibīn Al Kawm, Menoufiya, Egypt

National liver institute- menoufiya university

Mar 2, 2021